Pillstats
Rx only · Kit

Rasburicase

Brands: Elitek

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCV03AF07
RxCUI (US)283821
US makers1 labelers
Packages2
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

183653712025 Q12025 Q22025 Q32025 Q42026 Q1
28
Rx · 2026 Q1
78
Units dispensed
-54%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Sanofi-Aventis U.S. LLCunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Aug 10, 2020
    RECALLRecall (Class II): Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ, 08807, NDC…

    Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing. — Recalling firm: Sanofi-Aventis U.S. LLC — Nationwide in the US